Predicting lymph node metastases in patients with biopsy-proven ductal carcinoma in situ of the breast: development and validation of the dcis-met model

HIGHLIGHTS

• who: Claudia J. C. Meurs from the DepartmentUniversity of of Pathology Dordrecht, Dordrecht, The Netherlands have published the research: Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model, in the Journal: (JOURNAL)
• what: The aim of this observational study was to develop a prediction model for risk of lymph node metastasis in patients with a biopsy-proven DCIS. The model the authors developed had an AUC of 0.74. A strength of this study was that the model was developed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.